SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001600132-20-000030
Filing Date
2020-03-31
Accepted
2020-03-31 07:03:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 prospectussupplementmarch2.htm 424B5 435622
2 blphlogoa68.jpg GRAPHIC 32979
3 inopulseproducta25.jpg GRAPHIC 27238
  Complete submission text file 0001600132-20-000030.txt   519865
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-225878 | Film No.: 20759617
SIC: 2834 Pharmaceutical Preparations